Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering
Abstract
Share and Cite
Matesanz, A.; Sanz-Horta, R.; Gallardo, A.; Quílez, C.; Reinecke, H.; Acedo, P.; Velasco, D.; Martínez-Campos, E.; Jorcano, J.L.; Elvira, C. Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels 2025, 11, 540. https://doi.org/10.3390/gels11070540
Matesanz A, Sanz-Horta R, Gallardo A, Quílez C, Reinecke H, Acedo P, Velasco D, Martínez-Campos E, Jorcano JL, Elvira C. Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels. 2025; 11(7):540. https://doi.org/10.3390/gels11070540
Chicago/Turabian StyleMatesanz, Ana, Raúl Sanz-Horta, Alberto Gallardo, Cristina Quílez, Helmut Reinecke, Pablo Acedo, Diego Velasco, Enrique Martínez-Campos, José Luis Jorcano, and Carlos Elvira. 2025. "Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering" Gels 11, no. 7: 540. https://doi.org/10.3390/gels11070540
APA StyleMatesanz, A., Sanz-Horta, R., Gallardo, A., Quílez, C., Reinecke, H., Acedo, P., Velasco, D., Martínez-Campos, E., Jorcano, J. L., & Elvira, C. (2025). Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels, 11(7), 540. https://doi.org/10.3390/gels11070540

